Katia Dittus currently holds the position of PhD Student at the National Center for Tumor Diseases (NCT) Heidelberg since May 2022, following a role as a Master Thesis Student at the same institution from October 2021 to March 2022. Prior experience includes working as a Master Student at the DKFZ German Cancer Research Center from October 2018 to March 2022, and a Project Management Intern at Roche Diagnostics Europe from December 2020 to December 2021. Additional experience encompasses research roles at the Kolling Institute of Medical Research, NMI Natural and Medical Sciences Institute, and the University of Tübingen, along with an internship at the Desmond Tutu HIV Foundation. Katia Dittus earned a Master of Science in Molecular Bioscience from Heidelberg University and a Master’s degree with a major in Cancer Biology from DKFZ. Educational background also includes a study semester abroad in Immunology at the University of Cape Town.
This person is not in the org chart
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.